Details:

WP 9 Screening kick out on 1 and 2 of December, 2016 in Helsinki (Hilton Helsinki Kalastajatorppa, Kalastajatorpantie 1) Finland. 

More information: Screening work package from Ahti Anttila, ahti.anttila@cancer.fi 

Draft agenda:

1 December 2016

9:00 Opening Chairs: Nea Malila, Ahti Anttila
9:10 Welcome
Nea Malila, Finnish Cancer Registry / Cancer Society of Finland, Helsinki, Finland
Liisa-Maria Voipio-Pulkki, Ministry of Social Affairs and Health of Finland, Helsinki, Finland
Tit Albreht, National Institute of Public Health, Ljubljana, Slovenia

9:30 Overview of the meeting
Ahti Anttila, Finnish Cancer Registry, Helsinki, Finland

9:45 Session 1: Governance and effective implementation Chairs: Ondrej Majek, Stefan Lönnberg

• Introduction Ahti Anttila, Finnish Cancer Registry, Helsinki, Finland
• Implementation status of cancer screening in the European Union Carlo Senore, Center for Epidemiology and Prevention in Oncology, CPO Piedmont, Turin, Italy
• Good governance and organization models: summary of the Cancon recommendations Stefan Lönnberg, Cancer Registry of Norway, Oslo, Norway 
• Legal frameworks for population-based screening  Ondrej Majek, Masaryk University, Brno, Czech Republic

10:45 Coffee break
11:15 Country examples
How to align interests and make the effective population-based screening programme a common goal for all stakeholders; Common barriers and solutions – e.g. if lack of sustainable resources and funds, inadequate legal frameworks, divided professional stakeholders with diverging interests, lack of long-term political commitment [15+5 min for each presentation]
- UK Hilary Angwin,UK National Screening Committee, London, UK
- Germany Petra Uschold, Abteilung Medizin, GKV-Spitzenverband, Berlin, Germany
- Bulgaria Mirela Strandzeva, Directorate “Health Promotion and Disease Prevention” National Center of Public Health and Analyse, Sofia, Bulgaria
- Norway Maj Liv Eide, St Olav Hospital, Trondheim, Norway
- France Stéphanie Barré , INCA, Paris, France
- Poland Andrzej Nowakowski, Department of Gynaecology and Oncologic Gynaecology, Military Institute of Medicine, Warsaw, Poland

13:15 Lunch break

14:15 Session 2: Evaluation as a dimension of quality assurance Chairs: Mario Sekerija, Tytti Sarkeala

• Introduction Mario Sekerija, Croatian National Institute of Public Health, Zagreb, Croatia
• Dimensions and resourcing of quality assurance Tytti Sarkeala, Finnish Cancer Registry, Helsinki, Finland
• Successful coordination of pilot projects and rollout of cancer screening programmes Stephen Halloran, University of Surrey, Surrey, UK
• Tackling social inequalities in cancer prevention and control Rosana Peiro, Foundation for the Promotion of Health and Biomedical Research of Valencia Region, Valencia, Spain
• Case programmes: Innovative new approaches in monitoring and evaluation of cancer screening and related quality improvement; randomised trials or implementation on modifications screening programmes; improving equity and overcoming inequalities

1. SCREESCO Screening of Swedish Colons - a national study of colorectal cancer screening and       possibly an implementation of screening in Sweden Kaisa Fritzell, Karolinska Institutet, Karolinska   University Hospital, Stockholm Sweden
2. Strategies to improve the quality of colorectal cancer screening: The Basque Country model Isabel   Portillo-Villares, Programas de Detección del Cáncer Colorrectal y Cribado Prenatal, Osakidetza, Bilbao, Spain 
3. Implementing and improving UK Biennial Bowel Cancer Screening Stephen Halloran, University of Surrey, Surrey, UK 
4. Capacity improvement to implement cost-effective cancer screening in Romania Florian Nicula, The Oncology Institute “Prof. Dr. Ion Chiricute”, Cluj-Napoca, Romania
5. EU-TOPIA: developing road maps to improve the cancer screening programmes in Europe Eveline Heijnsdijk, Erasmus University Medical Center, Rotterdam, The Netherlands

15:20 Coffee break
15:50 Case programmes continues
17:30 End of meeting of the day 1
19:00 Dinner

2 December 2016

9:00 Session 3: Potential new screenings Chairs: Sirpa Heinävaara, Harry de Koning

• Introduction Sirpa Heinävaara, Finnish Cancer Registry, Helsinki, Finland
• Lung cancer Harry de Koning, Erasmus University Medical Center Rotterdam, The NetherlandsGastric cancer Marcis Leja, Riga East University Hospital, Riga, Latvia
• PSA screening pro versus con Harry de Koning, Erasmus University Medical Center, Rotterdam, The Netherlands & Anssi Auvinen, University of Tampere, Tampere, Finland
• General discussion

10:40 Coffee break

11:00 Session 4: Implementation, conclusions and further actions based on CANCON recommendations Chairs/facilitators: Sakari Karjalainen, Tit Albreht

• Moderators in small groups: David Ritchie, Jolanta Gore-Booth, Uros Rakic, Andrzej Nowakowski Interactive, involvement of all partners and meeting participants
• *Group work topics (initial ideas)
• Initiatives to implement Cancon results and recommendation in MSs (AN)
• Barriers in implementing Cancon recommendations in MSs and how try to overcome them (UR)
• What can European patient organisations, and other non-governmental organisations do to support implementation of Cancon recommendations (JGB)
• Initiatives how collaboration can be maintained and developed after the Cancon? (DR)

13:00 Closing

13.00 -14.00 Lunch